ROCK1 and glioblastoma: To further validate the TIMER results, we then perform ESTIMATE immune score analysis and find immune scores in 12 types of tumors (GBM, UCEC, LAM, CESC, STES, SARC, KIRP, LUSC, THYM, WT, SKCM-P, and PCPG) were negatively correlated to the ROCK1 expression levels (Figure 15B).